1287408008: Abrocitinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Janus kinase inhibitor\Abrocitinib

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Sulfone (substance)\Sulfonamide (substance)\Abrocitinib

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Abrocitinib

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Abrocitinib

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5258041013 Abrocitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5258042018 Abrocitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Abrocitinib	Is a	Sulfonamide (substance)	true	Inferred relationship	Some
Abrocitinib	Is a	Janus kinase inhibitor	true	Inferred relationship	Some
Abrocitinib	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Janus kinase inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Abrocitinib 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Abrocitinib	Inferred relationship	Some	1
Product containing precisely abrocitinib 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abrocitinib	Inferred relationship	Some	1
Product containing precisely abrocitinib 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Abrocitinib	Inferred relationship	Some	1
Product containing abrocitinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Abrocitinib	Inferred relationship	Some	1
Abrocitinib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Abrocitinib	Inferred relationship	Some	1

This concept is not in any reference sets